Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Apr;8(2):149-51.
doi: 10.1007/s13311-011-0043-3.

Neurotherapeutics. Editorial

Edward D Hall, Stephen M Onifer
Editorial

Neurotherapeutics. Editorial

Edward D Hall et al. Neurotherapeutics. 2011 Apr.
No abstract available

PubMed Disclaimer

References

    1. Bracken MB, Holford TR. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS II. J Neurosurg. 1993;79:500–507. doi: 10.3171/jns.1993.79.4.0500. - DOI - PubMed
    1. Bracken MB, Shepard MJ, Collins WF, Jr, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg. 1992;76:23–31. doi: 10.3171/jns.1992.76.1.0023. - DOI - PubMed
    1. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. NEJM. 1990;322:1405–1411. doi: 10.1056/NEJM199005173222001. - DOI - PubMed
    1. Hall E, Springer J. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx: J Am Soc Exp Neurother. 2004;1:80–100. - PMC - PubMed
    1. Hall ED. Antioxidant therapies for acute spinal cord injury. Neurotherapeutics 2011. doi:10.1007/s13311-011-0026-4. - PMC - PubMed

Publication types